Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
Dianthus Therapeutics (Nasdaq: DNTH), a clinical-stage biotech company focused on developing advanced antibody complement therapeutics for severe autoimmune diseases, has announced its participation in three major healthcare investor conferences in September 2024. CEO Marino Garcia will present corporate overviews at:
1. Baird 2024 Global Healthcare Conference on September 11 at 2:00 p.m. ET in New York City
2. Cantor 2024 Global Healthcare Conference on September 17 at 10:55 a.m. ET in New York City
3. Stifel 2024 Virtual Immunology and Inflammation Summit on September 18 at 10:30 a.m. ET via Zoom
Live webcasts of the Cantor and Stifel conference presentations will be available on the company's website under the Investors section.
Dianthus Therapeutics (Nasdaq: DNTH), una azienda biotech in fase clinica focalizzata nello sviluppo di terapie anticorpali avanzate per gravi malattie autoimmuni, ha annunciato la sua partecipazione a tre importanti conferenze per investitori nel settore sanitario a settembre 2024. Il CEO Marino Garcia presenterà panoramiche aziendali nei seguenti eventi:
1. Baird 2024 Global Healthcare Conference il 11 settembre alle 14:00 ET a New York
2. Cantor 2024 Global Healthcare Conference il 17 settembre alle 10:55 ET a New York
3. Stifel 2024 Virtual Immunology and Inflammation Summit il 18 settembre alle 10:30 ET tramite Zoom
Le webcast in diretta delle presentazioni delle conferenze Cantor e Stifel saranno disponibili sul sito web dell'azienda nella sezione Investitori.
Dianthus Therapeutics (Nasdaq: DNTH), una empresa biotecnológica en etapa clínica enfocada en desarrollar terapias avanzadas con anticuerpos para enfermedades autoinmunes severas, ha anunciado su participación en tres importantes conferencias de inversores en el sector salud en septiembre de 2024. El CEO Marino Garcia presentará resúmenes corporativos en:
1. Baird 2024 Global Healthcare Conference el 11 de septiembre a las 2:00 p.m. ET en Nueva York
2. Cantor 2024 Global Healthcare Conference el 17 de septiembre a las 10:55 a.m. ET en Nueva York
3. Stifel 2024 Virtual Immunology and Inflammation Summit el 18 de septiembre a las 10:30 a.m. ET a través de Zoom
Las transmisiones en vivo de las presentaciones de las conferencias Cantor y Stifel estarán disponibles en la sección de Inversores del sitio web de la empresa.
다이앤서스 치료법(Dianthus Therapeutics) (Nasdaq: DNTH), 심각한 자가면역 질환을 위한 고급 항체 보완 요법 개발에 집중하는 임상 단계의 생명 공학 회사는 2024년 9월에 있을 세 개의 주요 의료 투자자 회의에 참석한다고 발표했습니다. CEO 마리노 가르시아는 다음에서 기업 개요를 발표할 예정입니다:
1. 베어드 2024 글로벌 헬스케어 컨퍼런스(Baird 2024 Global Healthcare Conference)가 9월 11일 오후 2시(ET) 뉴욕 City에서 열립니다.
2. 칸토르 2024 글로벌 헬스케어 컨퍼런스(Cantor 2024 Global Healthcare Conference)가 9월 17일 오전 10시 55분(ET) 뉴욕시에서 열립니다.
3. 스티펠 2024 가상 면역학 및 염증 정상 회의(Stifel 2024 Virtual Immunology and Inflammation Summit)가 9월 18일 오전 10시 30분(ET) Zoom을 통해 열립니다.
칸토르 및 스티펠 회의 발표의 생중계는 회사 웹사이트의 투자자 섹션에서 확인 가능합니다.
Dianthus Therapeutics (Nasdaq: DNTH), une société de biotechnologie en phase clinique spécialisée dans le développement de thérapies basées sur des anticorps pour de graves maladies auto-immunes, a annoncé sa participation à trois grandes conférences d'investisseurs dans le domaine de la santé en septembre 2024. Le PDG Marino Garcia présentera des aperçus de l'entreprise lors des événements suivants :
1. Baird 2024 Global Healthcare Conference le 11 septembre à 14h00 ET à New York
2. Cantor 2024 Global Healthcare Conference le 17 septembre à 10h55 ET à New York
3. Stifel 2024 Virtual Immunology and Inflammation Summit le 18 septembre à 10h30 ET via Zoom
Les webdiffusions en direct des présentations des conférences Cantor et Stifel seront disponibles sur le site Web de l'entreprise dans la section Investisseurs.
Dianthus Therapeutics (Nasdaq: DNTH), ein biopharmazeutisches Unternehmen in der Klinikphase, das sich auf die Entwicklung fortgeschrittener Antikörpertherapien für schwere Autoimmunerkrankungen konzentriert, hat seine Teilnahme an drei bedeutenden Investorenkonferenzen im Gesundheitswesen im September 2024 bekanntgegeben. CEO Marino Garcia wird Unternehmenspräsentationen halten bei:
1. Baird 2024 Global Healthcare Conference am 11. September um 14:00 Uhr ET in New York City
2. Cantor 2024 Global Healthcare Conference am 17. September um 10:55 Uhr ET in New York City
3. Stifel 2024 Virtueller Immunologie und Entzündungsgipfel am 18. September um 10:30 Uhr ET über Zoom
Die Live-Übertragungen der Präsentationen der Cantor- und Stifel-Konferenzen sind auf der Website des Unternehmens im Bereich Investoren verfügbar.
- None.
- None.
NEW YORK and WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation and corporate overview presentations by Marino Garcia, Chief Executive Officer, at the following healthcare investor conferences during the month of September:
- Baird 2024 Global Healthcare Conference on September 11 at 2:00 p.m. ET in New York City
- Cantor 2024 Global Healthcare Conference on September 17 at 10:55 a.m. ET in New York City
- Stifel 2024 Virtual Immunology and Inflammation Summit on September 18 at 10:30 a.m. ET via Zoom
Live webcasts of the Company’s presentations at the Cantor and Stifel conferences may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.
About Dianthus Therapeutics
Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com
FAQ
What investor conferences will Dianthus Therapeutics (DNTH) attend in September 2024?
Who will be presenting at the investor conferences for Dianthus Therapeutics (DNTH)?
Will there be webcasts available for Dianthus Therapeutics' (DNTH) conference presentations?
What is the focus of Dianthus Therapeutics' (DNTH) research and development?
